Skip to main content

Table 3 Association of the top 20 leading companies’ global innovation activities with DALYs by income level and region

From: Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

 

Correlation coefficient (r)

Global

0.243

 Income levela

  High Income

0.617**

  Upper Middle Income

0.539*

  Lower Middle Income

0.067

  Low Income

−0.396

 Regionb

  European Region

0.596*

  Western Pacific Region

0.557*

  Region of the Americas

0.506*

  South-East Asia Region

0.232

  Eastern Mediterranean Region

0.161

  African Region

−0.414

  1. aClassified by the World Bank
  2. bClassified by the WHO
  3. *p < 0.05
  4. **p < 0.01
Back to article page

Globalization and Health

ISSN: 1744-8603